Tensor Medical accepts capital. A Spanish company specializing in the diagnosis and monitoring of neurodegenerative diseases has opened a round of 640,000 euros with the aim of increasing adoption of its solution against multiple sclerosis in twenty European centers and launch it on the market from the second half of 2023, as explained to PlantaDoce.
Multiple sclerosis affects more than 55,000 people in Spain and more than 2.8 million people worldwide. The annual costs of the disease exceed 2,000 million euros in Spain and 39,000 million euros in the whole of Europe.
Girona company develops radiological image biomarkers based on artificial intelligence (AI) for diagnosis and monitoring of neurodegenerative diseases. Tensor Medical has developed a platform for software which improves the assessment of the therapeutic response of patients with multiple sclerosis.
Tensor Medical is a spin around from the University of Girona (UdG) and the research institute of the Vall d’Hebron Hospital in Barcelona. The company’s platform also enables experts to efficiently assess patients’ therapeutic response and early detection of therapeutic failure, progress in decision-making on drug change.
Tensor Medical is seeking medical device certification for its software platform
The company estimates that using its platform at scale during clinical management of patients could mean a relative increase in quality of life measurements of more than 65% given their current condition and potential savings for health insurance payers. systems up to 600 million euros in Spain alone.
These days, Tensor Medical’s platform is being tested in more than five hospitals. The round will enable it to obtain certification as a medical device in the European and North American markets and attract talent in technology and business development to expand its solution and bring it to market.
Design and development of Tensor Medical solutions leads experts such as Alex Rovira and Xavier Montalban, from Vall d’Hebron Hospital, or Frederik Barkhof, from Vumc Hospital in Amsterdam and UCL in London. The developed technology is the result of more than twelve years of research into the development of neuroimaging solutions within the Vall d’Hebron Hospital in Barcelona.
Sergi Valverde is the co-founder and CEO of Tensor Medical. The CEO has experience in research and development of AI applications. Valverde has a doctorate in medical imaging from UdG and an MBA from the same university.
The team also includes Roger Bramon, who has experience in the development and integration of clinical applications in hospital environments and in the development of scalable machine learning systems in the cloud. Bramon is the former CTO of Starviewerradiological scanner installed in public hospitals and health centers of the Catalan health system.